Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Business Insurance
In the News
Provider choice proposals trending in comp
Workers' Comp
Conference
National Comp 2026
National Comp is the only national conference devoted to Workers’ Compensation and Disability Management Professionals.
Workers' Comp
Conference
80th Annual Workers’ Compensation Educational Conference and 37th Safety & Health Conference (WCI 2026)
Enlyte returns as an Elite Sponsor at WCI 2026 in Orlando—the nation's leading workers' compensation event.
Workers' Comp
Conference
RISKWORLD 2026
Meet us at RISKWORLD 2026!
Workers' Comp
Article
Specialty Solutions Spotlight: Cut Delays and Rework With Early DME Coordination
What’s the fastest way to keep workers’ compensation DME on schedule and within budget?
Mitchell
News Release
Electric Vehicle Collision Claims Rebound as Expiring U.S. Government Tax Incentives Drive Record Sales
SAN DIEGO, Calif.—Mitchell, a leader in the development of innovative auto physical damage